Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity.

AUTOR(ES)

Von Hoff, D D

RESUMO

Oncogene amplification has been observed in a broad spectrum of human tumors and has been associated with a poor prognosis for patients with several different types of malignancies. Importantly, at biopsy, the amplified genes localize to acentric extrachromosomal elements such as double-minute chromosomes (DMs) in the vast majority of cases. We show here that treatment of several human tumor cell lines with low concentrations of hydroxyurea accelerates the loss of their extrachromosomally amplified oncogenes. The decreases in MYC copy number in a human tumor cell line correlated with a dramatic reduction in cloning efficiency in soft agar and tumorigenicity in nude mice. No effect on gene copy number or tumorigenicity was observed for a closely related cell line containing the same number of chromosomally amplified MYC genes. One step involved in the accelerated loss of extrachromosomal elements is shown to involve their preferential entrapment of DMs within micronuclei. The data suggest that agents that accelerate the loss of extrachromosomally amplified genes could provide valuable tools for moderating the growth of a large number of human neoplasms.

Documentos Relacionados

• Restoration of CD44H expression in colon carcinomas reduces tumorigenicity.
• Rat embryo fibroblast cells expressing human papillomavirus 1a genes exhibit altered growth properties and tumorigenicity.
• Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc.
• Excision of N-myc from chromosome 2 in human neuroblastoma cells containing amplified N-myc sequences.
• Involvement of integrin alpha V gene expression in human melanoma tumorigenicity.